Viral Vector Core


Salk Institute for Biological Studies - Viral Vector Core - Overview


Edward Callaway Science

The staff within the Viral Vector Core - Gene Transfer, Targeting and Therapeutics Core (GT3) provide expert consultation for the safe and effective use of viral vector technologies, and offer custom design and production services for multiple viral vector types. The GT3 facilitates the use of these powerful research tools by Salk researchers and others across diverse fields of study such as systems neuroscience, stem cell biology, metabolism, ageing, cancer biology and gene therapy.

Due to recent changes in the Export Administration Regulations regarding rabies vectors, we are unable to distribute outside of the United States any reagents (viral vectors, plasmids, or cell lines) that contain any portion of the rabies genome.

Supported in part by:

National Cancer Institute
National Eye Institute
National Institute of Neurological Disorders and Stroke

The GT3 core is a designated Cancer Center Council (C3) core facility. Cancer Center members from participating C3 institutes have preferential rates.

Acknowledging Core Support

For submitting manuscripts that have made use of services or resources from this core, PLEASE ACKNOWLDGE SUPPORT by inclusion of the following information:

“This work was supported by the GT3 Core Facility of the Salk Institute with funding from NIH-NCI CCSG: P30 014195, an NINDS R24 Core Grant and funding from NEI” Please acknowledge core staff where appropriate and consider authorship inclusion when scientific contributions merit.

Please link each publication stemming from work performed in the core to your MyNCBI account. This will ensure that the contributions from NIH are appropriately acknowledged in renewal and continuation applications. This NIH requirement must be satisfied as part of our efforts to provide consistent access to stabling funded core resources. Information on how to link publications can be found here»

Research reported was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R24NS092943. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.


Salk Institute for Biological Studies

10010 N Torrey Pines Rd
La Jolla, CA 92037

Telephone: (858) 453-4100

(858) 453-4100 ext. 1891 (Director)
(858) 453-4100 ext. 1242 (Lab - Core Staff)

E-mail: (For ordering information and request submission).

Mailing Address:
Salk Institute, GT3
10010 N Torrey Pines Rd
La Jolla, CA 92037-1099

Our offices are located just North of the Salk Institute in the Sanford Consortium for Regenerative Medicine building.

Office Location
Room 1318

Lab Location
Room 1106